NO984162D0 - 5,11-dihydrobenzo(b,e)(1,4)oksazepinderivater og farmasöytiske sammensetninger inneholdende de samme - Google Patents

5,11-dihydrobenzo(b,e)(1,4)oksazepinderivater og farmasöytiske sammensetninger inneholdende de samme

Info

Publication number
NO984162D0
NO984162D0 NO984162A NO984162A NO984162D0 NO 984162 D0 NO984162 D0 NO 984162D0 NO 984162 A NO984162 A NO 984162A NO 984162 A NO984162 A NO 984162A NO 984162 D0 NO984162 D0 NO 984162D0
Authority
NO
Norway
Prior art keywords
compositions containing
dihydrobenzo
same
pharmaceutical compositions
eüä1
Prior art date
Application number
NO984162A
Other languages
English (en)
Other versions
NO310976B1 (no
NO984162L (no
Inventor
Yuji Tanaka
Keiji Misumi
Yoshinari Kawakami
Masahiko Moriguchi
Kazuyoshi Takahashi
Hiroki Okamoto
Toshiaki Kamisaki
Kimihiro Inoue
Makoto Sato
Original Assignee
Ajinomoto Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Kk filed Critical Ajinomoto Kk
Publication of NO984162D0 publication Critical patent/NO984162D0/no
Publication of NO984162L publication Critical patent/NO984162L/no
Publication of NO310976B1 publication Critical patent/NO310976B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19984162A 1996-03-11 1998-09-10 5,11-dihydrobenzo[b,e][1,4]oksazepinderivater og farmasoytiske sammensetninger inneholdende de samme NO310976B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8310496 1996-03-11
PCT/JP1997/000754 WO1997033885A1 (en) 1996-03-11 1997-03-11 5,11-DIHYDRODIBENZ[b,e][1,4]OXAZEPINE DERIVATIVES AND DRUG COMPOSITIONS CONTAING THE DERIVATIVES

Publications (3)

Publication Number Publication Date
NO984162D0 true NO984162D0 (no) 1998-09-10
NO984162L NO984162L (no) 1998-11-05
NO310976B1 NO310976B1 (no) 2001-09-24

Family

ID=13792896

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19984162A NO310976B1 (no) 1996-03-11 1998-09-10 5,11-dihydrobenzo[b,e][1,4]oksazepinderivater og farmasoytiske sammensetninger inneholdende de samme

Country Status (16)

Country Link
US (2) US6127361A (no)
EP (1) EP0889043B1 (no)
JP (1) JP3127469B2 (no)
KR (1) KR100344331B1 (no)
CN (1) CN1085209C (no)
AT (1) ATE204871T1 (no)
AU (1) AU704521B2 (no)
BR (1) BR9707962A (no)
CA (1) CA2261271C (no)
DE (1) DE69706406T2 (no)
ES (1) ES2159843T3 (no)
NO (1) NO310976B1 (no)
PT (1) PT889043E (no)
TW (1) TW479057B (no)
WO (1) WO1997033885A1 (no)
ZA (1) ZA972038B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999012925A1 (en) * 1997-09-10 1999-03-18 Ajinomoto Co., Inc. 5,11-DIHYDRODIBENZ[b,e][1,4]OXAZEPINE DERIVATIVES AND MEDICINAL COMPOSITION CONTAINING THE SAME
WO2000040570A1 (en) * 1999-01-08 2000-07-13 Ajinomoto Co., Inc. Oxazepine derivatives and drugs containing the same
WO2001017980A1 (en) * 1999-09-03 2001-03-15 Ajinomoto Co., Inc. Novel processes for preparing oxazepine derivatives
AU2001217359A1 (en) * 2000-12-11 2002-06-24 Ajinomoto Co., Inc. Novel crystals of oxazepine derivatives and process for the production thereof
JPWO2002096891A1 (ja) * 2001-05-30 2004-09-09 味の素株式会社 ジヒドロジアリールオキサゼピン誘導体及び該誘導体を含有する医薬組成物
JP2005343791A (ja) * 2002-05-31 2005-12-15 Ajinomoto Co Inc 消化管疾患を治療するための医薬組成物
JP2005343790A (ja) * 2002-05-31 2005-12-15 Ajinomoto Co Inc カルシウムチャネル拮抗薬を含有する医薬組成物
CN104016937B (zh) * 2014-05-09 2016-12-07 中科院广州化学有限公司 一种n-芳基氧氮杂卓酮类化合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8912303D0 (en) * 1989-05-27 1989-07-12 Pfizer Ltd Therapeutic agents
CA2118688A1 (en) * 1991-11-05 1993-05-13 Timothy J. Hagen Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
US20020183271A1 (en) * 2000-12-07 2002-12-05 Sunil Chada Methods of treatment involving human MDA-7

Also Published As

Publication number Publication date
EP0889043A4 (en) 1999-07-21
NO310976B1 (no) 2001-09-24
ES2159843T3 (es) 2001-10-16
DE69706406D1 (de) 2001-10-04
ATE204871T1 (de) 2001-09-15
PT889043E (pt) 2002-02-28
US6127361A (en) 2000-10-03
AU2233597A (en) 1997-10-01
EP0889043A1 (en) 1999-01-07
EP0889043B1 (en) 2001-08-29
TW479057B (en) 2002-03-11
AU704521B2 (en) 1999-04-22
KR100344331B1 (ko) 2002-12-05
DE69706406T2 (de) 2002-04-18
CA2261271C (en) 2003-09-16
WO1997033885A1 (en) 1997-09-18
CA2261271A1 (en) 1997-09-18
ZA972038B (en) 1997-09-17
KR19990087655A (ko) 1999-12-27
US6436922B1 (en) 2002-08-20
CN1213371A (zh) 1999-04-07
CN1085209C (zh) 2002-05-22
NO984162L (no) 1998-11-05
BR9707962A (pt) 1999-07-27
JP3127469B2 (ja) 2001-01-22

Similar Documents

Publication Publication Date Title
RU95108759A (ru) Фармацевтические соединения
DZ2494A1 (fr) Composition pharmaceutique d'oméprazole.
IL136285A0 (en) Pharmaceutical compositions containing an acid-labile active component
ITRM990338A0 (it) Composizione dietetica o farmaceutica utile per la prevenzione o il trattamento dell'iperossaluria.
HRP20000494B1 (en) Pharmaceutically active morpholinol
PH30006A (en) 9-¬(Substituted glycol)amido¾-6.demethyl-6-deoxytetra-cyclines
EP1334719A3 (en) Pentafluorobenzenesulfonamides and analogs
RU94035686A (ru) 4-ариламино-бензопиран и родственные соединения, фармацевтическая композиция, способ лечения
RU95106362A (ru) Производные липопептида, способ их получения, содержащая их фармацевтическая композиция и способ ее получения
TR199801268T2 (xx) Ta�ikinin antagonistleri olarak 3-Azetidinilalkilpiperidinler veya pirolidinler.
TR200001906T2 (tr) Koks-Inhibitörleri olarak 2,3-ikameli indol bileşikleri.
EA199900621A1 (ru) Лечение рассеянного склероза путем приема внутрь или ингаляции сополимера-1
EP0807633A3 (en) Novel 2,3-disubstituted-(5,6)- heteroarylfused-pyrimidine-4-ones
DE69631609D1 (en) Tricyclische erythromycinderivate
NO306116B1 (no) Ny benzotiadiazinforbindelse og farmasöytiske sammensetninger
GR3034821T3 (en) New 6-hydroxy and 6-oxo-anstro-stane derivatives active on the cardiovascular system and pharmaceutical compositions containing same
NO984162D0 (no) 5,11-dihydrobenzo(b,e)(1,4)oksazepinderivater og farmasöytiske sammensetninger inneholdende de samme
EA200000996A1 (ru) Конденсированные с арилом азаполициклические соединения
RU94040150A (ru) Стабильная лиофилизированная композиция тиотепа, способ ее получения
FI960658A0 (fi) Uudet bis-naftalimidit syövän hoitamiseksi
EP1073447A4 (en) N1-MODIFIED GLYCOPEPTIDES
RU95107655A (ru) Глюкопиранозидбензотиофены, способ получения, фармацевтическая композиция
KR970061248A (ko) 알츠하이머병 치료용 1, 1, 2-트리페닐부트-1-엔 유도체
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
PT1017681E (pt) Derivados de hidrazono-benzazuleno composicoes farmaceuticas e intermediarios